PerkinElmer Genetics, Inc.
Records under this name other than patents PerkinElmer Genetics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to PerkinElmer Genetics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,531,364 | Clinical method for the genetic screening of newborns using tandem mass spectrometry Term ended Term ended Sep 5, 2020 · USPTO record | Term ended | Term ended Sep 5, 2020 | USPTO record |
| US 7,297,545 | Clinical method for the genetic screening of newborns using tandem mass spectrometry and internal standards therefor Lapsed on the fee record Ended Nov 20, 2019 · USPTO record | Lapsed on the fee record | Ended Nov 20, 2019 | USPTO record |
| US 6,258,605 | Clinical method for the genetic screening of newborns using tandem mass spectrometry Term ended Term ended Mar 26, 2019 · USPTO record | Term ended | Term ended Mar 26, 2019 | USPTO record |
| US 6,455,321 | Method for interpreting tandem mass spectrometry data for clinical diagnosis Term ended Term ended Mar 26, 2019 · USPTO record | Term ended | Term ended Mar 26, 2019 | USPTO record |
| US 7,223,605 | Method for interpreting tandem mass spectrometry data for clinical diagnosis of genetic disorders such as citrullinemia Term ended Ended no later than Mar 26, 2019 · USPTO record | Term ended | Ended no later than Mar 26, 2019 | USPTO record |
| US 7,229,834 | Method for interpreting tandem mass spectrometry data for clinical diagnosis Term ended Ended no later than Mar 26, 2019 · USPTO record | Term ended | Ended no later than Mar 26, 2019 | USPTO record |
| US 7,238,531 | Method for interpreting tandem mass spectrometry data for clinical diagnosis Term ended Ended no later than Mar 26, 2019 · USPTO record | Term ended | Ended no later than Mar 26, 2019 | USPTO record |
| US 7,244,621 | Method for interpreting tandem mass spectrometry data for clinical diagnosis of genetic disorders such as hypermethionemia Term ended Ended no later than Mar 26, 2019 · USPTO record | Term ended | Ended no later than Mar 26, 2019 | USPTO record |